Concepedia

Hiroyoshi Horikoshi

HH

38

Publications

5.2K

Citations

25

H-Index

1971

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Biomedical Research Laboratories (United States)

The University of Tokyo

Daiichi Sankyo (Germany)

University of California San Diego

Hiroyoshi Horikoshi is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacology, and physiology.

Top concepts

MedicinePharmacologyDiabetesPhysiologyBiochemistryHealthMetabolic SyndromeMetabolismEndocrinologyMetabolic Regulation

Publications per year

1971–2009

38

Publications

38

Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1

Hiroyuki Tamemoto, Takashi Kadowaki, Kazuyuki Tobe et al. · Nature · 1994 · 1.1K citations

Insulin Resistance, Metabolic Syndrome, Insulin Signaling +11

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

Akira Okuno, Hiroyuki Tamemoto, Kazuuki TOBE et al. · Journal of Clinical Investigation · 1998 · 997 citations · Full text

Metabolic Disorder, Metabolic Remodeling, Insulin Signaling +22

Characterization of New Oral Antidiabetic Agent CS-045: Studies in KK and <i>ob/ob</i> Mice and Zucker Fatty Rats

Toshihiko Fujiwara, Shinji Yoshioka, Takao Yoshioka et al. · Diabetes · 1988 · 455 citations

Angptl3 regulates lipid metabolism in mice

Ryuta Koishi, Mitsuru Ono, Mitsuru Shimamura et al. · Nature Genetics · 2002 · 416 citations

Metabolic Syndrome, Signal Transduction, Lipid Metabolism +6

Effect of troglitazone on body fat distribution in type 2 diabetic patients.

Yuki Mori, Yūichi Murakawa, Keisuke Okada et al. · Diabetes Care · 1999 · 280 citations

Rows per page

1–5 of 38